Mandatory Drug Risk Information: How much information is too much? Ruth S. Day / Duke University FDA Public Hearing / Medication Guides Washington, DC -- June 12, 2007
Accutane Medication Guide Ruth Day
Basic Methods Study Test time All Multiple Content Tasks Ruth Day --benefits --risks --etc --attention --comprehension --memory
Basic Methods Study Test time All Multiple Content Tasks Ruth Day --benefits --risks --etc --attention --comprehension --memory
Basic Methods Study Test time All Multiple Content Tasks Ruth Day --benefits --risks --etc --attention --comprehension --memory
Key Educational Message Ruth Day
Key Educational Message “What is the most important information I should know about Accutane?” Ruth Day
Pregnancy % CORRECT Ruth Day
% CORRECT Pregnancy Ruth Day
% CORRECT Pregnancy Ruth Day
% CORRECT Pregnancy Ruth Day
% CORRECT Pregnancy Ruth Day
ACCUTANE Medication Guide Ruth Day Original Version
Ruth Day Original Who should not take Accutane?
Ruth Day Original
Enhanced Version ACCUTANE Medication Guide Ruth Day
New titles (Time Zones) Enhanced Ruth Day
Enhanced Ruth Day
Research Methods
Perceptions Opinions Attitudes
Research Methods Comprehension Memory Perceptions Opinions Attitudes
Perceptions Opinions Attitudes Research Methods Comprehension Memory
Perceptions Opinions Attitudes Research Methods Comprehension Memory
Study Test time Ruth Day PreTest PostTest Metacognition
UNDERSTAND REMEMBER PreTest PostTest PreTest PostTest very easy easy moderate hard very hard “How easy was it to understand the information in the leaflet?” Ruth Day
UNDERSTAND REMEMBER PreTest PostTest PreTest PostTest very easy easy moderate hard very hard “How easy was it to understand the information in the leaflet?” Ruth Day
UNDERSTAND REMEMBER PreTest PostTest PreTest PostTest very easy easy moderate hard very hard “How easy would it be to remember the information in the leaflet?” Ruth Day
Conclusions For FDA Advisory Committee (8/1/07)
--People overestimated how much they knew and understood after reading Ruth Day Conclusions For FDA Advisory Committee (8/1/07)
--People overestimated how much they knew and understood after reading --After testing, they realized they knew less than they thought Ruth Day Conclusions For FDA Advisory Committee (8/1/07)
--People overestimated how much they knew and understood after reading --After testing, they realized they knew less than they thought -- AND they actually knew far less than that. Ruth Day Conclusions For FDA Advisory Committee (8/1/07)